Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95 | 942 | 139 | N/A | 2 |
| Receivables | 127 | 149 | 42 | N/A | N/A |
| TOTAL | $432 | $1,576 | $205 | $N/A | $2 |
| Non-Current Assets | |||||
| PPE Net | 74 | 77 | 88 | N/A | 1 |
| Other Non-Current Assets | 31 | 31 | 31 | 0 | 0 |
| TOTAL | $105 | $108 | $119 | $N/A | $1 |
| Total Assets | $537 | $1,685 | $324 | $N/A | $3 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,842 | 3,488 | 6,120 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,241 | 943 | 1,767 | 0 | 3 |
| Accrued Expenses | 432 | 445 | 1,422 | N/A | N/A |
| Other current liabilities | N/A | N/A | 91 | N/A | N/A |
| TOTAL | $6,195 | $5,543 | $10,826 | $N/A | $3 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,009 | 3,149 | 2,902 | N/A | N/A |
| Deferred Revenues | 13 | 39 | 79 | N/A | N/A |
| Other Non-Current Liabilities | 57 | 57 | 19,476 | 0 | 0 |
| TOTAL | $3,066 | $3,207 | $22,382 | $N/A | $N/A |
| Total Liabilities | $9,261 | $8,750 | $33,208 | $N/A | $3 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 535 | 508 | 195 | 195 | 195 |
| Common Shares | 15 | 15 | 5 | N/A | 6 |
| Retained earnings | -47,240 | -44,984 | -42,573 | N/A | -56 |
| Other shareholders' equity | -500 | -500 | -184 | 0 | 0 |
| TOTAL | $-8,724 | $-7,066 | $-32,885 | $N/A | $-1 |
| Total Liabilities And Equity | $537 | $1,685 | $324 | $0 | $3 |